0.05Open0.05Pre Close0 Volume173 Open Interest24.00Strike Price0.00Turnover8407.51%IV34.58%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0435Delta0.0309Gamma357.40Leverage Ratio-88.9273Theta0.0000Rho15.56Eff Leverage0.0000Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet